To assess the effect of combined inhibition of PARP and MCL1 in this model, PDX tumor cells were orthotopically injected into NOD-SCID-IL2Rγc–/– mice (n = 48), which were randomly allocated to vehicle-, single- or double-treatment arms once tumors reached a volume of 100 mm3. This evidence concerns the gene MCL1 and neoplasm.